Kodiak Sciences Inc.
NASDAQKodiak Sciences reports Q2 results on August 14 carrying one of the more charged short-interest profiles in small-cap biotech, with nearly a fifth of its free float bet against it heading into a binary data catalyst. Short sellers are firmly dug in. Short interest in KOD runs at 19.8% of the free float — roughly 10.5 million shares — a level that has held remarkably stable over the…
Snapshot as of 11 Aug 2026
Kodiak Sciences reports Q2 results on August 14 carrying one of the more charged short-interest profiles in small-cap biotech, with nearly a fifth of its free float bet against it heading into a binary data…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for KOD — free to start on ORTEX.
Sign up for free →Open KOD on ORTEX